Quantitative optical coherence tomography angiography biomarkers of the choriocapillaris for objective detection of early diabetic retinopathy

脉络膜毛细血管定量光学相干断层扫描血管造影生物标志物在早期糖尿病视网膜病变客观检测中的应用

阅读:1

Abstract

PURPOSE: To evaluate quantitative optical coherence tomography (OCT) angiography (OCTA) biomarkers from the choriocapillaris (CC) for detecting early microvascular changes associated with diabetic retinopathy (DR). MATERIALS AND METHODS: In this retrospective study, 191 macular OCTA images were analyzed from 78 healthy eyes, 64 eyes from diabetic individuals without clinical signs of DR (NoDR), and 49 eyes with mild nonproliferative DR (NPDR). Five CC biomarkers were extracted from 6 mm × 6 mm enface OCTA images: flow deficit density (FDD), FD number (FDN), mean FD size (MFDS), perfusion intensity density (PID), and normalized blood flow index (NBFI). Flow maps were binarized using Phansalkar local thresholding, and statistical comparisons were performed using one-way analysis of variance and two-sample t-tests. RESULTS: All five biomarkers demonstrated significant differences across study groups (P < 0.001). FDD and MFDS were significantly elevated in both NoDR and mild NPDR eyes compared to controls, indicating increased nonperfusion and enlargement of flow voids. FDN decreased with disease severity, indicating spatial consolidation of capillary loss. PID and NBFI, which reflect flow signal intensity, also declined in diabetic eyes, suggesting a reduction in overall CC perfusion consistent with early vascular compromise. CONCLUSION: Quantitative OCTA biomarkers of the CC reveal early microvascular changes in diabetic eyes. Among them, FDN and MFDS demonstrated the highest sensitivity to early disease progression. These findings support the use of CC-derived OCTA features as potential imaging biomarkers for detecting and monitoring early diabetic microvascular dysfunction.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。